Insider Transactions in Q4 2020 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+4.18%
|
$180,000
$18.5 P/Share
|
|
Dec 04
2020
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
662
-3.25%
|
$12,578
$19.85 P/Share
|
|
Dec 04
2020
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,042
+4.86%
|
-
|
|
Dec 04
2020
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,652
+21.96%
|
-
|
|
Oct 26
2020
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
101
-0.52%
|
$2,020
$20.95 P/Share
|
|
Oct 26
2020
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+1.06%
|
-
|
|
Oct 15
2020
|
Peter P. Pfreundschuh Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,400
-6.66%
|
$50,400
$21.78 P/Share
|
|
Oct 15
2020
|
Peter P. Pfreundschuh Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,917
+27.75%
|
-
|